Eczema Health Care Use Down for Non-Hispanic Black Children

This article originally appeared here.
Share this content:
Eczema Health Care Use Down for Non-Hispanic Black Children
Eczema Health Care Use Down for Non-Hispanic Black Children

THURSDAY, Oct. 12, 2017 (HealthDay News) -- Non-Hispanic black children have lower health care utilization for eczema, according to a study published online Sept. 27 in the Journal of the American Academy of Dermatology.

Using data from the two-year cohorts of the 2001 to 2013 Medical Expenditure Panel Surveys, Alexander H. Fischer, M.D., M.P.H., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues performed a cohort study involving 2,043 non-Hispanic white (reference), non-Hispanic black, and Hispanic white individuals aged under 18 years with caregiver reported eczema. The authors assessed health care utilization over a two-year follow-up period by race/ethnicity.

The researchers found that the likelihood of reporting an ambulatory visit for eczema was lower for non-Hispanic blacks than whites (adjusted odds ratio, 0.69) among all children with eczema. Among those with one or more ambulatory visit for eczema, more visits and prescriptions were reported by non-Hispanic blacks than whites (adjusted incidence ratio, 1.68 and 1.22, respectively); they were also more likely to report a dermatology visit for eczema (adjusted odds ratio, 1.82).

"Our findings suggest disparities in health care utilization for eczema among non-Hispanic black children despite utilization patterns suggestive of more severe disease," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Extended-Release Naltrexone Promising for Opioid Dependence

Extended-Release Naltrexone Promising for Opioid Dependence

Lower use of heroin, other illicit opioids with extended-release naltrexone in superiority analysis

New Expert Consensus Pathway for Mitral Regurgitation

New Expert Consensus Pathway for Mitral Regurgitation

Etiology, mechanism, severity, indications for treatment should be assessed after MR is identified

Many Dermatology Guideline Authors Get Industry Payments

Many Dermatology Guideline Authors Get Industry Payments

22 of 40 guideline authors receiving payments did not accurately disclose industry relationships

is free, fast, and customized just for you!

Already a member?

Sign In Now »